Junshi Biosciences’ Subsidiary Secures EU GMP Certification, Strengthening Loqtorzi’s Market Prospects
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180), a leading biopharmaceutical company based in...
AFT Pharmaceuticals Partners with Hainan Haiyao for Distribution of Crystaderm Cream in China
AFT Pharmaceuticals (JSE: AFT, ASX: ASX), a company based in New Zealand, has announced an...
Amgen Halts Development of Claudin 6-Targeting BiTE Immune Therapy AMG 794
Amgen Inc. (NASDAQ: AMGN), a leading biopharmaceutical company based in the U.S., has decided to...
Kymera Therapeutics’ Stock Soars on Sanofi’s Plans to Expand KT-474 Clinical Trials
Kymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical company based in the U.S., has announced that...
BGI Genomics’ Subsidiary Inks 3-Year Noninvasive Prenatal Test Agreement with Heilongjiang Province
BGI Genomics Co., Ltd (SHE: 300676), a leading genomics company based in China, has announced...
Shanghai Vitalgen BioPharma Launches Phase I/II Gene Therapy Trial for Parkinson’s Disease
Shanghai Vitalgen BioPharma Co., Ltd, a biopharmaceutical company based in China, has initiated a Phase...
Kintor Pharmaceutical Launches Global Cosmetic Line with Hair Loss Treatment Pyrilutamide
Kintor Pharmaceutical Ltd (HKG: 9939), a biopharmaceutical company based in China, has announced the global...
Suzhou Sanegene Bio Receives NMPA Approval for Clinical Trial of Antihypertensive siRNA Drug
Suzhou Sanegene Bio Inc., a leading RNAi specialist with research and development centers in both...
Shanghai Junshi Biosciences’ HDAC Inhibitor JS125 Clinical Trial Application Accepted by NMPA
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced that the National Medical...
Johnson & Johnson’s Opsumit Faces Generic Competition with Qilu Pharmaceutical’s Entry
Johnson & Johnson (J&J, NYSE: JNJ)’s pulmonary hypertension treatment, Opsumit (macitentan), is set to encounter...
China Isotope & Radiation Corporation Secures NMPA License for Innovative Radiotherapy System
China Isotope & Radiation Corporation (CIRC; HKG: 1763) has announced that it has received a...
Staidson Pharmaceutical Gets NMPA Green Light for Neurotrophic Keratitis Eye Drop Clinical Trial
Staidson (Beijing) Pharmaceutical Co., Ltd (SHE: 300204), a biopharmaceutical company based in China, has announced...
GSK China Vaccine Head Peggy Fung Resigns, Departure Set for Mid-August
Peggy Fung, GSK’s Vice President and Head of Vaccine Business in China, has opted to...
GRIT Biotechnology and Quangang Pharmaceutical Co., Ltd Partner to Develop TIL and IL-2 Combination Therapy
GRIT Biotechnology, a leading cell therapy specialist based in China, has entered into a strategic...
US House Speaker Mike Johnson Revives Possibility of Biosecure Act Vote
US House of Representatives Speaker Mike Johnson has suggested that a vote on the Biosecure...
Shandong Buchang Pharmaceuticals Receives NMPA Approval for BC008-1A Biologic Product Clinical Trial
Shandong Buchang Pharmaceuticals Co., Ltd (SHA: 603858), a pharmaceutical company based in China, has announced...
HOB Biotech Receives NMPA Approval for Clinical Trials of MM09 Sublingual Spray
Jiangsu-based HOB Biotech Group Corp., Ltd (SHA: 688656) has announced that it has received clinical...
Hugo Biotech Partners with Watchmaker Genomics to Develop Infectious Disease Detection Solutions
Hugo Biotech, a biotech company based in Beijing, has entered into a partnership with Watchmaker...
Moderna Partners with Mitsubishi Tanabe for mRNA Vaccine Promotion in Japan
Moderna Inc. (NASDAQ: MRNA), a leading mRNA specialist biotechnology company based in the U.S., has...
Eli Lilly & Co. to Acquire Morphic Holding Inc. in a USD 3.2 Billion Deal
Eli Lilly & Co. (NYSE: LLY), a leading pharmaceutical company in the U.S., has announced...